Prediabetes in End Stage Renal Disease on Dialysis

Prediabetes is a highly prevalent condition, affecting about one-third of adults in the United States Patients with prediabetes have an increased risk for diabetes, with 2% to 10% progressing to diabetes each yea Although prediabetes is frequently considered an intermediary stage in the progression between normoglycemia and diabetes, many individuals may have prediabetes for several years, while some may never progress.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Screening Chronic Disease Chronic Renal Failure (CRF) Dialysis Patients Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Intolerance Glucose Metabolism Disorders Hyperglycemia Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Pre Diabetic Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine, Sohag, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

End stage renal disease on dialysis patients aged ≥ 18 years old.

Exclusion criteria

Patients previously diagnosed with prediabetes.
Patients previously diagnosed with diabetes mellitus.
Acute Medical Status :Hospitalized patients.
Physiological States: Pregnant females.Lactating females.
Specific Comorbidities & Conditions: Polycystic kidney disease.
New York Heart Association (NYHA) class III or IV heart failure.
Known liver cirrhosis. or HIV/AIDS.
Renal cancer.
Active immunosuppression. or Recent chemotherapy or immunosuppressive therapy.
History of organ transplantation.

Treatment and study plan

Primary outcomes

The prevalence of prediabetes in the End Stage Renal Disease (ESRD) on dialysis cohort.

Time frame: "The time frame for measurement of the primary outcome (prevalence of prediabetes) with all diagnostic measurements (Fasting Plasma Glucose mg/dl) performed once per participant at the time of their inclusion in the study."

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Screening of Prediabetes in End Stage Renal Disease on Dialysis

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Jan 13, 2026
Registry last updated: Jan 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting